mRNA Vaccine Cuts COVID-Related Guillain-Barré Risk : c

COVID-19 increases the risk for Guillain-Barré syndrome sixfold, while getting the Pfizer mRNA vaccine lowers risk.

Related Keywords

Arbel , Ha Afon , Israel , Haya Bishara , Eitan Auriel , Medscape Coronavirus Resource Center , Lady Davis Carmel Medical Center , Boehringer Ingelheim , Pfizer , Israel Institute Of Technology , Novo Nordisk , Coronavirus Resource , Anat Arbel , Technion Israel Institute , Lady Davis Carmel Medical , Coronavirus , 019 Novel Coronavirus , 019 Ncov , Uhan Coronavirus , Uman Coronavirus Hku1 , Uman Coronavirus Oc43 , Cov Oc43 , Uman Coronavirus 229e , Cov 229e , Covid 19 Vaccine , Coronavirus Vaccine , Guillain Barre Syndrome , Immunizations , Vaccination , Vaccine , Biologic Therapy , Antigens , Hospitals , Icd 10 , Healthcare Technology , Ealth Care Technology ,